Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal for Immunotherapy of Cancer
|
June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Daniel G Coit, John A Thompson, Mark R Albertini, et al.
Cancer Discovery
|
November 12, 2021
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Kenneth F Grossmann, Megan Othus, Sapna P Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Christopher K Bichakjian, Thomas Olencki, Sumaira Z Aasi, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019
P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
Craig L Slingluff, Karl D Lewis, Robert Andtbacka, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TIL
Hongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal for Immunotherapy of Cancer
|
June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Daniel G Coit, John A Thompson, Mark R Albertini, et al.
Cancer Discovery
|
November 12, 2021
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Kenneth F Grossmann, Megan Othus, Sapna P Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Christopher K Bichakjian, Thomas Olencki, Sumaira Z Aasi, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019
P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
Craig L Slingluff, Karl D Lewis, Robert Andtbacka, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TIL
Hongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Page
of 7